Justification-Maintenance of a Technical Advisory Group for United States Representation
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA), under the Department of Health and Human Services, has published a Justification for Other Than Full and Open Competition for the Maintenance of a Technical Advisory Group for United States Representation. This action justifies a sole-source, Firm-Fixed Price Purchase Order to the American National Standards Institute (ANSI) for Fiscal Year 2026, valued at $495,600.00.
Justification & Scope
This document justifies the award to ANSI to serve as the administrator of the US/TAG to ISO/TC 34/SC 9. ANSI's role involves coordinating U.S. participation in international standards activities. The justification is made pursuant to FAR 6.302-1, citing that ANSI is the only responsible source capable of satisfying agency requirements.
Contract Details
- Type: Firm-Fixed Price Purchase Order
- Proposed Contractor: American National Standards Institute (ANSI)
- Estimated Cost: $495,600.00
- Period of Performance: FY 2026
- Published Date: May 27, 2026
- Set-Aside: Not applicable (Justification for Other Than Full and Open Competition)
Rationale for Sole Source
The rationale for this sole-source award is based on ANSI's unique position as the sole U.S. member body to the International Organization for Standardization (ISO), a status codified in international agreements and ISO membership structure. Market research confirmed that no other U.S. organization possesses the necessary authority, international recognition, or acceptance required to fulfill the Government's needs. Previous similar actions were also not competed under the same FAR authority.
Additional Information
This notice is a justification for a sole-source award and is not a solicitation for proposals. Interested parties should note that this is an informational posting regarding an intended non-competitive award.
Contact Information
- Primary Contact: Natalie Brown (Natalie.Brown@fda.hhs.gov)
- Secondary Contact: Ian Weiss (Ian.Weiss@fda.hhs.gov, 301-796-5728)